Condition
Vaso-Occlusive Crises
Total Trials
5
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 3 (1)
Trial Status
Recruiting3
Not Yet Recruiting1
Terminated1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07498309Phase 3Not Yet RecruitingPrimary
Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease
NCT07246265Not ApplicableRecruiting
Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
NCT07369024Phase 2Recruiting
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
NCT07001189Recruiting
Impact of Regional Anesthesia on Inflammatory Mechanisms During Vaso-occlusive Crisis in Sickle Cell Patients
NCT02698761Not ApplicableTerminated
A Comprehensive Care Plan for Pediatric Patients With Vaso-Occlusive Crises
Showing all 5 trials